Next Article in Journal
Ovarian Morphometric and Histologic Characteristics and Correlation with Clinical Factors: A Cross-Sectional Study
Next Article in Special Issue
Robotic Gastrointestinal Surgery: State of the Art and Future Perspectives
Previous Article in Journal
Port Placement Variations for Robotic Lung Resection: Focusing on Their History, Conventional Look-Up-View and Horizontal Open-Thoracotomy-View Techniques, and More
Previous Article in Special Issue
The Role of Robotic Visceral Surgery in Patients with Adhesions: A Systematic Review and Meta-Analysis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Systematic Review

Robotic Surgery and Functional Esophageal Disorders: A Systematic Review and Meta-Analysis

1
Department of Clinical Medicine and Surgery, University of Naples “Federico II”, 80131 Naples, Italy
2
Department of Advanced Biomedical Sciences, University of Naples “Federico II”, 80131 Naples, Italy
*
Author to whom correspondence should be addressed.
J. Pers. Med. 2023, 13(2), 231; https://doi.org/10.3390/jpm13020231
Submission received: 30 October 2022 / Revised: 7 January 2023 / Accepted: 22 January 2023 / Published: 27 January 2023
(This article belongs to the Special Issue Update on Robotic Gastrointestinal Surgery)

Abstract

:
The functional disease of the esophago-gastric junction (EGJ) is one of the most common health problems. It often happens that patients suffering from GERD need surgical management. The laparoscopic fundoplication has been considered the gold standard surgical treatment for functional diseases of the EGJ. The aim of our meta-analysis is to investigate functional outcomes after robotic fundoplication compared with conventional laparoscopic fundoplication. A prospective search of online databases was performed by two independent reviewers using the search string “robotic and laparoscopic fundoplication”, including all the articles from 1996 to December 2021. The risk of bias within each study was assessed with the Cochrane ROBINS-I and RoB 2.0 tools. Statistical analysis was performed using Review Manager version 5.4. In addition, sixteen studies were included in the final analysis, involving only four RCTs. The primary endpoints were functional outcomes after laparoscopic (LF) and robotic fundoplication (RF). No significant differences between the two groups were found in 30-day readmission rates (p = 0.73), persistence of symptomatology at follow-up (p = 0.60), recurrence (p = 0.36), and reoperation (p = 0.81). The laparoscopic fundoplication represents the gold standard treatment for the functional disease of the EGJ. According to our results, the robotic approach seems to be safe and feasible as well. Further randomized controlled studies are required to better evaluate the advantages of robotic fundoplication.

1. Introduction

The functional disease of the esophago-gastric junction (EGJ) is one of the most common health problems, affecting more than 50% of the world’s population and resulting in a serious deterioration of quality of life with important economic implications [1]. Medical treatment with a proton pump inhibitor (PPI) can help control reflux symptoms, but on the other hand, it implies cost-effective, long-lasting medicine-based treatment. It often happens that GERD patients do not achieve complete control of the symptoms, needing surgical management [2].
The laparoscopic fundoplication has been performed with patient satisfaction since its introduction during the twentieth century, becoming the gold standard for the surgical treatment of functional disease of the EGJ [3,4].
Additionally, after the first robotic-assisted Nissen fundoplication (RALF) reported by Cadiere in 1999 [5], it has been debated if the robotic approach could improve surgical outcomes due to the three-dimensional view and the enhanced manipulation of instruments [6] compared with the conventional laparoscopic fundoplication (CLF). Several previous studies have demonstrated the safety and feasibility of a robot-assisted approach in this setting [7,8,9,10].
The aim of our meta-analysis is to investigate the functional outcomes after minimally invasive surgery, both laparoscopic and robotic, for the treatment of functional disease of the EGJ.

2. Materials and Methods

2.1. Literature Search and Eligibility Criteria

This systematic review complied with PRISMA (preferred reporting items for systematic reviews and meta-analyses) reporting standards [11] and was developed in line with MOOSE (meta-analysis of observational studies in epidemiology) guidelines [12].
A prospective search of Embase, PubMed, SCOPUS, and Web of Science was performed using the search string “robotic and laparoscopic fundoplication”.
The analysis included all the articles from 1996 to December 2021. The last search was performed in January 2022.
Case reports, case series without a control group, indexed abstracts of posters and podium presentations at international meetings, and non-English articles were excluded. Systematic reviews and meta-analyses were only consulted to identify additional studies of interest. In addition, the reference lists of the retrieved studies were manually reviewed. In cases of overlapping series in different studies, only the most recent article was included. Publications with no data about functional results after minimally invasive fundoplication were also excluded.
The research question was structured using the PICO (problem/population, intervention, comparison, and outcome) framework. The populations of interest included patients affected by functional esophageal disease (GERD, hiatal hernia, or paraesophageal hernia). The intervention was robotic fundoplication, and the comparator was laparoscopic fundoplication. The functional outcomes after surgery were analyzed: 30-day readmission; persistent symptomatology at follow-up, including delayed gastric emptying; postoperative pyrosis or dysphagia; disease recurrence; need for reintervention.
The literature search and study selection were performed independently by two reviewers (S.V. and A.D.), showing a high level of inter-reader agreement (κ = 1). In case of disagreement, a third investigator (Mi.Ma.) was consulted, and an agreement was reached by consensus.

2.2. Data Extraction and Assessment of Risk of Bias in Included Studies

The titles and abstracts were screened and reviewed independently by S.V. and A.D., followed by full-text reading. In addition, ineligible studies were excluded after full-text reading. The data extraction was conducted independently and in duplicate by the two reviewers. Further, the data extraction form was created in accordance with the guidelines in the Cochrane Handbook for systematic reviews of interventions by the consensus of both reviewers.
The following data were extracted from each included study: first author, year of publication, study design, period of study, surgical indication, sample size, number of patients in each surgical group, gender, mean age, mean BMI, type of intervention (Nissen, Dor, Toupet, or no fundoplication), redo surgery, operative time, 30 days readmission, mean follow-up, persistence of symptomatology at follow-up, complaining of delayed gastric emptying, pyrosis, or dysphagia, needing of reintervention. The data extracted from studies were then separated into the following sections: study characteristics, population characteristics, intervention characteristics, and functional outcomes.
Additionally, after data extraction was completed, the risk of bias within each study was assessed.
The Cochrane ROBINS-I (Risk of Bias in Non-randomized Studies of Interventions) tool [13], which is a risk of bias tool to assess the quality of non-randomized studies of interventions, was adopted to evaluate the methodological quality of each cohort-type study. The scoring system encompasses seven domains. The first two domains, covering confounding and selection of participants into the study, address issues before the start of the interventions that are to be compared (“baseline”). The third domain addresses the classification of the interventions themselves. The other four domains address issues after the start of interventions: biases due to deviations from intended interventions, missing data, measurement of outcomes, and selection of the reported result. The categories for risk of bias judgments are “low risk”, “moderate risk”, “serious risk”, “critical risk”, and “no information” when insufficient data are reported to permit a judgment.
In cases of randomized controlled trials (RCTs), the risk of bias was evaluated using the revised Cochrane Risk of Bias tool (RoB 2.0) [14]. According to this scoring system, seven domains were evaluated as “low risk of bias”, “high risk of bias”, or “unclear” according to the reporting on sequence generation, allocation concealment, blinding of participants, blinding of outcome assessment, incomplete outcome data, selective outcome reporting, and other potential threats to validity.

2.3. Statistical Analysis

The statistical analysis was performed using Review Manager (RevMan Version 5.4, Copenhagen, Denmark: The Nordic Cochrane Centre, The Cochrane Collaboration, 2020).
The primary outcomes of this study were the functional results after robotic fundoplication in patients suffering from GERD, hiatal hernia, or paraesophageal hernia compared to a laparoscopic approach. In addition, the differences among cases and controls were expressed as risk difference (RD) with pertinent 95% CI for dichotomous variables, to maintain analytic consistency and include all available data, according to Messori et al. [15]; the differences among cases and controls were expressed as mean difference (MD) with pertinent 95% confidence intervals (95% CI) for continuous variables. The risk difference represents the difference between the observed risks (proportions of individuals with the outcome of interest) in the two groups. If studies reported only the median, range, and size of the trial, the means and standard deviations were calculated according to Luo et al. and Wan et al. [16,17]. When studies reported only means for continuous variables and the sample size of the trial, a standard deviation was imputed, according to Furukawa et al. [18].
The overall effect was tested using Z scores, and significance was set at p < 0.05. Statistical heterogeneity between studies was tested by the Q statistic and quantified by the I2 statistic, a measurement of the inconsistency across study results and a description of the proportion of total variation in study estimates, that is due to heterogeneity rather than sampling error. In detail, an I2 value of 0% indicates no heterogeneity, 25% low, 25–50% moderate, and >50% high heterogeneity [19].
According to DerSimonian and Laird [20], the random-effects model was used for all analyses to account for the heterogeneity among included studies.
The presence of publication bias was investigated through a funnel plot, where the summary estimate of each study (Risk Difference) was plotted against a measure of study precision (Standard Error). In addition to visual inspection and the funnel plot, symmetry was tested using Egger’s linear regression method. [21] p values < 0.05 were considered statistically significant.

3. Results

3.1. Study Selection

A total of 339 articles were identified from electronic databases. After the removal of duplicate studies, 287 publications were screened according to the PRISMA flowchart (Figure 1).
Of the 72 articles that were selected for the title and abstract, 51 studies were excluded because they did not meet the inclusion criteria. Furthermore, the online full version of five articles was not available, and it was not possible to extract data from the abstract. The remaining 16 studies [22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37] were selected as they met the eligibility criteria and were included in the final analysis.

3.2. Baseline Characteristics of the Included Studies

This meta-analysis included 16 monocentric studies published between 2002 and 2021, involving 1064 patients suffering from GERD, hiatal hernia, or paraesophageal hernia, whereof 618 underwent laparoscopic and 445 robotic fundoplication, respectively. There were 4 RCT [27,32,33,34], 10 retrospective [22,23,24,25,26,28,29,30,35,36], and 2 prospective [31,37] trials. The number of patients ranged between 12 and 687, the mean age was between 3.8 and 72.5 years, and the mean BMI varied from 10.1 kg/m2 to 37.0 kg/m2.
Major characteristics of the studies are shown in Table 1.
Intervention characteristics are described in detail in Table 2. Nissen fundoplication (360°) was performed in fourteen studies [22,24,25,26,27,28,30,31,32,33,34,35,36,37], Toupet fundoplication (270°) was reported in seven papers [23,25,29,31,35,36,37], Dor fundoplication (180°) was described in two articles [29,36], while in only one study [35] Watson partial anterior fundoplication was performed. Only two studies [22,36] included redo fundoplications.

3.3. Risk of Bias

The Cochrane RoB 2.0 and ROBINS-I tools were used to assess the quality of the included papers.
Additionally, regarding the four randomized controlled trials, only one study [33] reported a low risk of bias. The other three studies [27,32,34] showed a high risk of bias, with the major bias due to deviations from the intended interventions, i.e., conversions to an open approach. Two conversions from laparoscopy were described by Draaisma et al. [27], and two conversions from the robotic approach were reported by Morino et al. and Nakadi et al. [32,34].
Due to the nature of the surgical interventions, blinding was impossible, but the results are unlikely to be affected by the lack of blinding.
All non-randomized studies reported a risk of bias due to baseline confounding. Only three [22,26,31] authors with a consequent moderate risk of bias performed propensity score matching, while the other nine [23,24,25,28,29,30,35,36,37] had a severe risk of bias due to insufficient adjustment for confounding domains.
The results of the RoB 2.0 and ROBINS-I quality assessments are reported in Figure 2a,b and Figure 3a,b, which were created with Robvis (Risk-of-Bias VISualization), a web app that facilitates rapid production of publication-quality risk-of-bias assessment figures.

3.4. Primary Outcomes

The functional outcomes after laparoscopic (LF) and robotic fundoplication (RF) were analysed during a mean follow up period of 1-93.6 months, as described in Table 3.

3.4.1. 30-Days Readmission Rates

Only seven authors [22,23,25,26,33,35,37] reported 30-day readmission rates including 434 patients (207 RF and 227 LF) with no significant differences between the two groups [p = 0.73, RD = 0.00, 95% CI (−0.02, 0.03)]. No heterogeneity among the studies [Tau2 = 0.00; Chi2 = 0.85; df = 6 (p = 0.99); I2 = 0%] was reported (Figure 4).

3.4.2. Persistence of Symptoms

Eleven studies [22,24,25,27,29,31,33,34,35,36,37] investigated the persistence of symptomatology after almost 1 month of follow-up. In addition, apart from two studies [25,37], which reported no ongoing symptoms, in the other nine [22,24,27,29,31,33,34,35,36], a total of 164 of the 641 patients referred reported lasting symptomatology without statistically significant differences between robotic and laparoscopic procedures (p = 0.60). Neither heterogeneity among the studies [Tau2 = 0.00; Chi2 = 6.19; df = 10 (p = 0.80); I2 = 0%] was described (Figure 5).
In particular, thirteen studies [22,23,24,26,27,30,31,32,33,34,35,36,37] reported the presence of postoperative dysphagia without significant differences between the two groups [39/387 RF and 47/529 LF, p = 0.77, RD = 0.00, 95% CI (−0.03, 0.02)]. Supplementary Materials: Figure S1.
Seven authors [22,23,25,28,30,36,37] reported data regarding delayed gastric emptying: a total of 6 patients in each group had gastric paresis at follow-up, with no statistically significant differences between the two groups [6/215 RF vs. 6/242 LF; p = 0.99, RD = 0.00, 95% CI (−0.02, 0.02)]. Supplementary Materials: Figure S2.
Only five articles [31,32,34,35,36] described the presence of postoperative pyrosis in 11 of 117 patients for the robotic group and 15 of 122 patients for the laparoscopic group, with no statistically significant differences between the two groups [p = 0.58, RD = −0.02, 95% CI (−0.09, 0.05)]. Supplementary Materials: Figure S3.

3.4.3. Recurrence

In nine studies [22,24,25,27,30,31,33,34,37], recurrence of symptoms of reflux was described in 22 patients (5 RF and 17 LF), with no significant differences between the two groups [p = 0.36, RD = −0.02, 95% CI (−0.07, 0.03)]. The moderate heterogeneity among the studies [Tau2 = 0.00; Chi2 = 13.42; df = 8 (p = 0.10); I2 = 40%] was reported (Figure 6).

3.4.4. Reoperation

A total of nine studies [22,25,27,30,31,33,34,36,37] reported reintervention during follow-up involving 22 patients with no significant differences between the two groups [p = 0.81, RD = 0.00, 95% CI (−0.04, 0.03)]. In addition, ten patients underwent reintervention after an initially successful robotic fundoplication: five experienced troublesome dysphagia [27,30,33,36], three had persistent GERD symptoms [36], one had an incisional hernia at the umbilicus [27], and another patient with a gastric torsion underwent a laparoscopic procedure with reduction of the torsion and fixation of the anterior gastric wall to the abdominal wall [34]. In the laparoscopic group, twelve patients were subject to reoperation during follow-up for persistent symptoms: six presented recurrent GERD symptoms [30,31,36] and six had severe dysphagia [27,30]. No heterogeneity among the studies [Tau2 = 0.00; Chi2 = 2.58; df = 8 (p = 0.96); I2 = 0%] was reported (Figure 7).

3.5. Publication Bias

It is recognized that publication bias can affect the results of meta-analyses; thus, we attempted to assess this potential bias using funnel plot analysis performed with Comprehensive Meta-analysis Software (CMA v.2). In evaluating all the analysed outcomes, we observed a symmetrical distribution of the studies without any publication bias by the Egger’s linear regression method (30-day readmission p = 0.84; recurrence p = 0.23; reoperation p = 0.60; persistence of symptomatology p = 0.12) (Supplementary Materials: Figures S4–S7).

4. Discussion

The functional disease of the esophago-gastric junction (EGJ) is a common health problem that often causes a serious deterioration of quality of life. Sometimes GERD patients do not achieve complete control of the symptoms with medical treatment with a proton pump inhibitor (PPI), needing surgical management.
Up until now, laparoscopic fundoplication has been considered the gold standard for the surgical treatment of functional disease of the EGJ [3,4].
Additionally, after the first robotic-assisted Nissen fundoplication (RALF) [5], it has been debated if the robotic approach could improve surgical outcomes compared with the conventional laparoscopic fundoplication (CLF) [6], considering the documented safety and feasibility of the robot-assisted approach in this setting [7,8,9,10].
It could be rational to hypothesize advantages of robotic surgery to improve functional results; limitations of laparoscopic procedures due to lack of dexterity, lack of tactile sense, magnification of natural tremors, and two-dimensional visualization could be overcome.
However, the robotic technique presents an important limitation that is related to the high functional costs, as shown by Hartmann et al. [29], Morino et al. [32], and Albassam et al. [22], due to the instrumentation and reusable materials, the nursing costs, the investment costs, and the maintenance costs [34].
According to current literature, there is no clear evidence as to which minimally invasive surgical approach is superior for the treatment of functional diseases of the EGJ. In addition, to the best of our knowledge, this is the first meta-analysis reported on the comparative efficacy of available interventions in the management of functional diseases of the EGJ.
Several limitations must be considered in our study: first, because of the novelty of this topic, few studies are present in the literature. In fact, only 16 studies [22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37] published between 2002 and 2021 could be included in this meta-analysis, with a narrow sample size of 1064 patients suffering from GERD, hiatal hernia, or paraesophageal hernia.
Then, only four studies were RCTs [27,32,33,34] and two were prospective trials [31,37]. All the other ten included studies were retrospective [22,23,24,25,26,28,29,30,35,36]; the observed results in each study could be affected by many factors, such as standards in patients’ selection, the surgeon’s experience, or technical details.
It is important to highlight that no one study had functional results as its primary outcome.
According to our results, both robotic and laparoscopic fundoplication are effective as well, reporting no significant differences between the two groups in terms of 30-day readmission rates (p = 0.73), lasting of symptomatology at almost 1 month of follow-up (p = 0.60), recurrence of symptoms of reflux (p = 0.36), and needing for reintervention during follow-up (p = 0.81). Moreover, two conversions from laparoscopy were described by Draaisma et al. [27], and two conversions from the robotic approach were reported by Morino et al. and Nakadi et al. [32,34]. Although nowadays the risk of conversion to open surgery has decreased due to higher surgeon expertise, it is important to underline that the conversion rate from robotic surgery is lower than that from laparoscopy, according to current literature [38,39,40].
Furthermore, regarding the persistence of symptomatology after 1 month from the intervention, no differences were found in postoperative dysphagia (p = 0.77), gastric paresis (p = 0.99) and postoperative pyrosis (p = 0.58). It is fair to specify that both persistence of symptomatology and recurrence could appear even after years with a treatment failure rate of 40%, as shown by Spechler SJ [41]. However, there is a lack of data concerning a follow-up longer than five years for both the medical and surgical approaches.
Even if, on the basis of our results, we can state that the robotic approach was effective and feasible for the surgical treatment of the functional disease of EGJ, we cannot declare any advantage on the basis of the functional analysis results. Both laparoscopic and robotic approaches could be selected to perform a Nissen fundoplication. On the other hand, the current literature presents a lack of ad hoc papers evaluating some important features, such as:
-
the functional outcomes obtained by a laparoscopic versus robotic approach.
-
data concerning a follow-up longer than 5 years for both medical and surgicalapproach.
-
indications and parameters for GERD-surgery.
The rationale is that robotic surgery should improve functional outcomes due to the magnified view and endowrist technology. However, it required making a call for future well-designed multicentre high-quality randomized controlled studies to evaluate the functional outcomes after robotic surgery for the treatment of functional disease of the EGJ, indications and parameters for GERD-surgery, and the long-term follow-up longer than 5 years.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/jpm13020231/s1. Figure S1: Forest plot of laparoscopic vs. robotic persistence of postoperative dysphagia [22,23,24,26,27,30,31,32,33,34,35,36,37]; Figure S2: Forest plot of laparoscopic vs. robotic presence of gastric paresis [22,23,25,28,30,36,37]; Figure S3: Forest plot of laparoscopic vs. robotic presence of postoperative pyrosis [31,32,34,35,36]. Figure S4: Funnel plot of 30-day readmission rates; Figure S5: Funnel plot of recurrence of reflux symptoms; Figure S6: Funnel plot of reoperation; Figure S7: Funnel plot of persistence of symptomatology.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki. This study involved a systematic review and meta-analysis; as such, ethical review and approval were waived.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Darling, G.; Deschamps, C. Technical Controversies in Fundoplication Surgery. Thorac. Surg. Clin. 2005, 15, 437–444. [Google Scholar] [CrossRef] [PubMed]
  2. Dallemagne, B.; Weerts, J.M.; Jehaes, C.; Markiewicz, S.; Lombard, R. Laparoscopic Nissen fundoplication: Preliminary report. Surg. Laparosc. Endosc. 1991, 1, 138–143. [Google Scholar] [PubMed]
  3. Wright, A.S.; Gould, J.C.; Melvin, W.S. Computer-assisted robotic antireflux surgery. Minerva Gastroenterol. E Dietol. 2004, 50, 253–260. [Google Scholar]
  4. Lunca, S.; Bouras, G.; Stanescu, A.C. Gastrointestinal robot-assisted surgery. A current perspective. Rom. J. Gastroenterol. 2005, 14, 385–391. [Google Scholar] [PubMed]
  5. Cadière, G.B.; Himpens, J.; Vertruyen, M.; Bruyns, J.; Fourtanier, G. Fundoplicature Selon Nissen Réalisée à Distance Du Pa-tient Par Robotique [Nissen Fundoplication Done by Remotely Controlled Robotic Technique]. Ann. Chir. 1999, 53, 137–141. [Google Scholar]
  6. Ruurda, J.P.; Draaisma, W.A.; van Hillegersberg, R.; Rinkes, I.H.B.; Gooszen, H.G.; Janssen, L.W.; Simmermacher, R.K.; Broeders, I.A. Robot-Assisted Endoscopic Surgery: A Four-Year Single-Center Experience. Dig. Surg. 2005, 22, 313–320. [Google Scholar] [CrossRef]
  7. Brenkman, H.J.; Parry, K.; van Hillegersberg, R.; Ruurda, J.P. Robot-Assisted Laparoscopic Hiatal Hernia Repair: Promising Anatomical and Functional Results. J. Laparoendosc. Adv. Surg. Tech. 2016, 26, 465–469. [Google Scholar] [CrossRef]
  8. Falkenback, D.; Lehane, C.W.; Lord, R.V.N. Robot-assisted oesophageal and gastric surgery for benign disease: Antireflux operations and Heller’s myotomy. ANZ J. Surg. 2014, 85, 113–120. [Google Scholar] [CrossRef]
  9. Kastenmeier, A.; Gonzales, H.; Gould, J.C. Robotic Applications in the Treatment of Diseases of the Esophagus. Surg. Laparosc. Endosc. Percutaneous Tech. 2012, 22, 304–309. [Google Scholar] [CrossRef]
  10. Mi, J.; Kang, Y.; Chen, X.; Wang, B.; Wang, Z. Whether robot-assisted laparoscopic fundoplication is better for gastroesophageal reflux disease in adults: A systematic review and meta-analysis. Surg. Endosc. 2010, 24, 1803–1814. [Google Scholar] [CrossRef]
  11. Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E.; et al. The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews. BMJ 2021, 372, n71. [Google Scholar] [CrossRef] [PubMed]
  12. Brooke, B.S.; Schwartz, T.A.; Pawlik, T.M. MOOSE Reporting Guidelines for Meta-analyses of Observational Studies. JAMA Surg. 2021. [Google Scholar] [CrossRef] [PubMed]
  13. Sterne, J.A.C.; Hernán, M.A.; Reeves, B.C.; Savović, J.; Berkman, N.D.; Viswanathan, M.; Henry, D.; Altman, D.G.; Ansari, M.T.; Boutron, I.; et al. ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016, 355, i4919. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Higgins, J.P.T.; Altman, D.G.; Gøtzsche, P.C.; Jüni, P.; Moher, D.; Oxman, A.D.; Savović, J.; Schulz, K.F.; Weeks, L.; Sterne, J.A.C.; et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 2011, 343, d5928. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Messori, A.; Maratea, D.; Fadda, V.; Trippoli, S. Using risk difference as opposed to odds-ratio in meta-analysis. Int. J. Cardiol. 2013, 164, 127. [Google Scholar] [CrossRef]
  16. Luo, D.; Wan, X.; Liu, J.; Tong, T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat. Methods Med Res. 2018, 27, 1785–1805. [Google Scholar] [CrossRef] [Green Version]
  17. Wan, X.; Wang, W.; Liu, J.; Tong, T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res. Methodol. 2014, 14, 1–13. [Google Scholar] [CrossRef] [Green Version]
  18. Furukawa, T.A.; Barbui, C.; Cipriani, A.; Brambilla, P.; Watanabe, N. Imputing missing standard deviations in meta-analyses can provide accurate results. J. Clin. Epidemiol. 2006, 59, 7–10. [Google Scholar] [CrossRef]
  19. Barili, F.; Parolari, A.; Kappetein, P.; Freemantle, N. Statistical Primer: Heterogeneity, random- or fixed-effects model analyses? Interact. Cardiovasc. Thorac. Surg. 2018, 27, 317–321. [Google Scholar] [CrossRef] [Green Version]
  20. DerSimonian, R.; Laird, N. Meta-analysis in clinical trials. Control Clin. Trials 1986, 7, 177–188. [Google Scholar] [CrossRef]
  21. Egger, M.; Smith, G.D.; Schneider, M.; Minder, C. Papers Bias in Meta-Analysis Detected by a Simple, Graphical Test. BMJ 1997, 315, 629–631. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Albassam, A.A.; Mallick, M.S.; Gado, A.; Shoukry, M. Nissen Fundoplication, Robotic-assisted Versus Laparoscopic Procedure: A Comparative Study in Children. Eur. J. Pediatr. Surg. 2009, 19, 316–319. [Google Scholar] [CrossRef] [PubMed]
  23. Benedix, F.; Adolf, D.; Peglow, S.; Gstettenbauer, L.M.; Croner, R. Short-term outcome after robot-assisted hiatal hernia and anti-reflux surgery—Is there a benefit for the patient? Langenbeck’s Arch. Surg. 2021, 406, 1387–1395. [Google Scholar] [CrossRef] [PubMed]
  24. Ceccarelli, G.; Patriti, A.; Biancafarina, A.; Spaziani, A.; Bartoli, A.; Bellochi, R.; Casciola, L. Intraoperative and Postoperative Outcome of Robot-Assisted and Traditional Laparoscopic Nissen Fundoplication. Eur. Surg. Res. 2009, 43, 198–203. [Google Scholar] [CrossRef] [PubMed]
  25. Ceccarelli, G.; Pasculli, A.; Bugiantella, W.; De Rosa, M.; Catena, F.; Rondelli, F.; Costa, G.; Rocca, A.; Longaroni, M.; Testini, M. Minimally invasive laparoscopic and robot-assisted emergency treatment of strangulated giant hiatal hernias: Report of five cases and literature review. World J. Emerg. Surg. 2020, 15, 1–12. [Google Scholar] [CrossRef]
  26. Copeland, D.R.; Boneti, C.; Kokoska, E.R.; Jackson, R.J.; Smith, S.D. Evaluation of Initial Experience and Comparison of the da Vinci Surgical System With Established Laparoscopic and Open Pediatric Nissen Fundoplication Surgery. JSLS J. Soc. Laparosc. Robot. Surg. 2008, 12, 238–240. [Google Scholar]
  27. Draaisma, W.A.; Ruurda, J.P.; Scheffer, R.C.H.; Simmermacher, R.K.J.; Gooszen, H.G.; Jong, H.G.R.; Buskens, E.; Broeders, I.A.M.J. Randomized clinical trial of standard laparoscopic versus robot-assisted laparoscopic Nissen fundoplication for gastro-oesophageal reflux disease. Br. J. Surg. 2006, 93, 1351–1359. [Google Scholar] [CrossRef] [Green Version]
  28. Gehrig, T.; Mehrabi, A.; Fischer, L.; Kenngott, H.; Hinz, U.; Gutt, C.N.; Müller-Stich, B.P. Robotic-assisted paraesophageal hernia repair—A case–control study. Langenbeck’s Arch. Surg. 2012, 398, 691–696. [Google Scholar] [CrossRef]
  29. Hartmann, J.; Menenakos, C.; Ordemann, J.; Nocon, M.; Raue, W.; Braumann, C. Long-term results of quality of life after standard laparoscopic vs. robot-assisted laparoscopic fundoplications for gastro-oesophageal reflux disease. A comparative clinical trial. Int. J. Med Robot. Comput. Assist. Surg. 2009, 5, 32–37. [Google Scholar] [CrossRef]
  30. Jensen, J.S.; Antonsen, H.K.; Durup, J. Two years of experience with robot-assisted anti-reflux surgery: A retrospective cohort study. Int. J. Surg. 2017, 39, 260–266. [Google Scholar] [CrossRef]
  31. Melvin, W. Computer-Enhanced vs. Standard Laparoscopic Antireflux Surgery. J. Gastrointest. Surg. 2002, 6, 11–16. [Google Scholar] [CrossRef] [PubMed]
  32. Morino, M.; Pellegrino, L.; Giaccone, C.; Garrone, C.; Rebecchi, F. Randomized clinical trial of robot-assisted versus laparoscopic Nissen fundoplication. Br. J. Surg. 2006, 93, 553–558. [Google Scholar] [CrossRef] [PubMed]
  33. Müller-Stich, B.P.; Reiter, M.A.; Mehrabi, A.; Wente, M.N.; Fischer, L.; Köninger, J.; Gutt, C.N. No relevant difference in quality of life and functional outcome at 12 months’ follow-up—A randomised controlled trial comparing robot-assisted versus conventional laparoscopic Nissen fundoplication. Langenbeck’s Arch. Surg. 2009, 394, 441–446. [Google Scholar] [CrossRef]
  34. El Nakadi, I.; Mélot, C.; Closset, J.; De Moor, V.; Bétroune, K.; Feron, P.; Lingier, P.; Gelin, M. Evaluation of da Vinci Nissen Fundoplication Clinical Results and Cost Minimization. World J. Surg. 2006, 30, 1050–1054. [Google Scholar] [CrossRef]
  35. Samar, A.M.; Bond, A.; Ranaboldo, C. Comparison of FreeHand® robot-assisted with human-assisted laparoscopic fundoplication. Minim. Invasive Ther. Allied Technol. 2020, 31, 24–27. [Google Scholar] [CrossRef]
  36. Tolboom, R.C.; Draaisma, W.A.; Broeders, I.A.M.J. Evaluation of conventional laparoscopic versus robot-assisted laparoscopic redo hiatal hernia and antireflux surgery: A cohort study. J. Robot. Surg. 2016, 10, 33–39. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Wilhelm, A.; Nocera, F.; Schneider, R.; Koechlin, L.; Daume, D.L.; Fourie, L.; Steinemann, D.; von Flüe, M.; Peterli, R.; Angehrn, F.V.; et al. Robot-assisted vs. laparoscopic repair of complete upside-down stomach hiatal hernia (the RATHER-study): A prospective comparative single center study. Surg. Endosc. 2021, 1–9. [Google Scholar] [CrossRef]
  38. Jayne, D.; Pigazzi, A.; Marshall, H.; Croft, J.; Corrigan, N.; Copeland, J.; Quirke, P.; West, N.; Rautio, T.; Thomassen, N.; et al. Effect of Robotic-Assisted vs Conventional Laparoscopic Surgery on Risk of Conversion to Open Laparotomy Among Patients Undergoing Resection for Rectal Cancer: The ROLARR Randomized Clinical Trial. JAMA 2017, 318, 1569–1580. [Google Scholar] [CrossRef] [PubMed]
  39. Milone, M.; de’Angelis, N.; Beghdadi, N.; Brunetti, F.; Manigrasso, M.; De Simone, G.; Servillo, G.; Vertaldi, S.; De Palma, G.D. Conversions related to adhesions in abdominal surgery. Robotic versus laparoscopic approach: A multicentre experience. Int. J. Med Robot. Comput. Assist. Surg. 2020, 17, e2186. [Google Scholar] [CrossRef]
  40. Milone, M.; Manigrasso, M.; Anoldo, P.; D’Amore, A.; Elmore, U.; Giglio, M.C.; Rompianesi, G.; Vertaldi, S.; Troisi, R.I.; Francis, N.K.; et al. The Role of Robotic Visceral Surgery in Patients with Adhesions: A Systematic Review and Meta-Analysis. J. Pers. Med. 2022, 12, 307. [Google Scholar] [CrossRef]
  41. Spechler, S.J. Evaluation and Treatment of Patients with Persistent Reflux Symptoms Despite Proton Pump Inhibitor Treatment. Gastroenterol. Clin. N. Am. 2020, 49, 437–450. [Google Scholar] [CrossRef] [PubMed]
Figure 1. PRISMA 2020 flow diagram.
Figure 1. PRISMA 2020 flow diagram.
Jpm 13 00231 g001
Figure 2. Summary of risk of bias for RCT studies [27,32,33,34].
Figure 2. Summary of risk of bias for RCT studies [27,32,33,34].
Jpm 13 00231 g002
Figure 3. Summary of risk of bias for non-RCT studies [22,23,24,25,26,28,29,30,31,35,36,37].
Figure 3. Summary of risk of bias for non-RCT studies [22,23,24,25,26,28,29,30,31,35,36,37].
Jpm 13 00231 g003
Figure 4. Forest plot of laparoscopic vs. robotic 30day readmission rates [22,23,25,26,33,35,37].
Figure 4. Forest plot of laparoscopic vs. robotic 30day readmission rates [22,23,25,26,33,35,37].
Jpm 13 00231 g004
Figure 5. Forest plot of laparoscopic vs. robotic persistence of symptomatology [22,24,25,27,29,31,33,34,35,36,37].
Figure 5. Forest plot of laparoscopic vs. robotic persistence of symptomatology [22,24,25,27,29,31,33,34,35,36,37].
Jpm 13 00231 g005
Figure 6. Forest plot of laparoscopic vs. robotic recurrence of reflux symptoms [22,24,25,27,30,31,33,34,37].
Figure 6. Forest plot of laparoscopic vs. robotic recurrence of reflux symptoms [22,24,25,27,30,31,33,34,37].
Jpm 13 00231 g006
Figure 7. Forest plot of laparoscopic vs. robotic reoperation rates [22,25,27,30,33,34,36,37].
Figure 7. Forest plot of laparoscopic vs. robotic reoperation rates [22,25,27,30,33,34,36,37].
Jpm 13 00231 g007
Table 1. Baseline characteristics of the included studies.
Table 1. Baseline characteristics of the included studies.
StudyStudy DesignStudy
Period
Patients
(n)
Male/Female
(n)
Age
(years) (SD)
BMI
(kg/m2) (SD)
Diagnosis
TotalLapRobLapRobLapRobLapRob
Albassam AA et al., 2009 [22]RetrospectiveJan. 2005–Jul. 20085025259/1611/143.8
(3.25)
5.4
(3.42)
10.9
(4.65)
10.1
(3.14)
GERD
Benedix F et al., 2021 [23]RetrospectiveJan. 2016–Jul. 2020140855529/5618/3762.9
(11.6)
63.5
(12.3)
29.3
(3.8)
29.5
(4.4)
Hiatal hernia and GERD
Ceccarelli G et al., 2009 [24]RetrospectiveOct. 1992–Sep. 200718313745--52.5
(8.3)
55.0
(11.75)
27.0
(2.0)
28.0
(3.0)
GERD
Ceccarelli G et al., 2020 [25]RetrospectiveDec. 2009–Dec. 20195232/03/072.5
(13.5)
68.3
(14.2)
30.0
(2.6)
29.1
(5.6)
Giant Hiatal hernia
Copeland DR et al., 2008 [26]Retrospective1994–20051005050--8.9
(5.9)
9.75
(5.3)
33.0
(24.0)
37.0
(23.0)
-
Draaisma WA et al., 2006 [27]RCTJan. 2003–Oct. 200550252517/816/950.5
(12.7)
39.0
(0.5)
31.0
(7.0)
27.0
(4.5)
GERD
Gehrig T et al., 2013 [28]Retrospective2003–200729171212/53/960.2
(11.8)
68.1
(7.9)
26.6
(4.4)
25.4
(2.6)
Paraesophageal hernia
Hartmann J et al., 2009 [29]RetrospectiveJan. 2003–Dec. 200380621830/339/953.0
(14.0)
57.0
(13.0)
30.0
(4.7)
27.2
(4.3)
GERD
Jensen JS et al., 2017 [30]RetrospectiveApr. 2013–Apr. 2015103643923/4118/2149.4
(15.4)
52.0
(14.6)
26.9
(3.4)
26.5
(3.1)
GERD
Melvin WS et al., 2002 [31]Prospective-4020207/1313/749.6
(0.5)
42.9
(0.5)
--GERD
Morino M et al., 2006 [32]RCT-50252518/719/646.3
(11.3)
43.0
(12.8)
26.1
(2.3)
25.5
(2.9)
GERD
Muller-Stich BP et al., 2009 [33]RCTAug. 2004–Dec. 200540202012/810/1050.5
(12.4)
49.6
(12.0)
26.2
(3.4)
29.2
(5.83)
GERD
Nakadi IE et al., 2006 [34]RCT-201198/36/348.0
(4.0)
44.0
(4.0)
24.8
(0.7)
25.3
(1.2)
GERD
Samar AM et al., 2020 [35]RetrospectiveJan. 2014–Jun. 201644261813/139/955.7
(8.2)
49.2
(7.75)
---
Tolboom RC et al., 2016 [36]RetrospectiveJan. 2008–Dec. 201375304511/1912/3357.2
(2.2)
56.0
(2.2)
--Hiatal hernia and GERD
Wilhelm A et al., 2021 [37]ProspectiveJuly 2015–June 20195519365/1413/2371.7 (13.5)69.0
(11.5)
29.0
(6.5)
30.0
(3.5)
Hiatal hernia
Table 2. Intervention characteristics.
Table 2. Intervention characteristics.
StudyDe Novo
Surgery
Redo
Surgery
Nissen
Fundoplication
Dor
Fundoplication
Toupet
Fundoplication
No
Fundoplication
Operative Time
(min)
LapRobLapRobLapRobLapRobLapRobLapRobLapRob
Albassam AA et al., 2009 [22]2424112525000000193.12
(26.6)
186.04
(21,1)
Benedix F et al., 2021 [23]----0000855500125.0
(35.5)
149.0
(42.1)
Ceccarelli G et al., 2009 [24]----1374500000086.2
(14.2)
65.0
(10.8)
Ceccarelli G et al., 2020 [25]230011001101165.0
(5.0)
203.3
(17.8)
Copeland DR et al., 2008 [26]5050005050000000107.0
(31.0)
160.0
(61.0)
Draaisma WA et al., 2006 [27]25250-2525000000115.0
(37.5)
125.0
(25.0)
Gehrig T et al., 2013 [28]17120096000086168.0
(42.0)
172.0
(31.0)
Hartmann J et al., 2009 [29]6218000062180000116.0
(63.0)
207.0
(45.0)
Jensen JS et al., 2017 [30]64390049150015240086.0
(19.0)
135.0
(27.0)
Melvin WS et al., 2002 [31]2020001717003300101.7
(30.7)
160.2
(45.7)
Morino M et al., 2006 [32]252500252500000091.1
(10.6)
131.6
(18.3)
Muller-Stich BP et al., 2009 [33]2020002020000000102.0
(19.0)
88.0
(18.0)
Nakadi IE et al., 2006 [34]1190011900000096.0
(5.0)
137.0
(12.0)
Samar AM et al., 2020 [35]----1537 *2 *41300164.0
(43.0)
129.0
(22.0)
Tolboom RC et al., 2016 [36]0030456421220271298.7
(6.2)
120.0
(2.5)
Wilhelm A et al., 2021 [37]----4000152907179.5
(42.0)
182.2
(6.9)
* Watson partial anterior fundoplication (120°).
Table 3. Functional outcomes.
Table 3. Functional outcomes.
StudyMean Follow-Up
(months)
30-days Readmission
(n)
Persistence
of Symptoms
(n)
Delayed Gastrinc Emptying
(n)
Pyrosis
(n)
Dysphagia
(n)
Recurrence
(n)
Reoperation
(n)
LapRobLapRobLapRobLapRobLapRobLapRobLapRobLapRob
Albassam AA et al., 2009 [22]19.2519.250010912--100000
Benedix F et al., 2021 [23]3323--00--85--11
Ceccarelli G et al., 2009 [24]93.643.2--155----3152--
Ceccarelli G et al., 2020 [25]66000000----0000
Copeland DR et al., 2008 [26]1100------1415----
Draaisma WA et al., 2006 [27]66--12----213122
Gehrig T et al., 2013 [28]------20------01
Hartmann J et al., 2009 [29]----185-0--------
Jensen JS et al., 2017 [30]22.526----00--421052
Melvin WS et al., 2002 [31]10.56.7--1813-043536010
Morino M et al., 2006 [32]1212------0000----
Muller-Stich BP et al., 2009 [33]12120055----012001
Nakadi IE et al., 2006 [34]1212--21--00000001
Samar AM et al., 2020 [35]11--115--2242----
Tolboom RC et al., 2016 [36]11.73--1623339636--44
Wilhelm A et al., 2021 [37]28.731000001--110200
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Vertaldi, S.; D’Amore, A.; Manigrasso, M.; Anoldo, P.; Chini, A.; Maione, F.; Pesce, M.; Sarnelli, G.; De Palma, G.D.; Milone, M. Robotic Surgery and Functional Esophageal Disorders: A Systematic Review and Meta-Analysis. J. Pers. Med. 2023, 13, 231. https://doi.org/10.3390/jpm13020231

AMA Style

Vertaldi S, D’Amore A, Manigrasso M, Anoldo P, Chini A, Maione F, Pesce M, Sarnelli G, De Palma GD, Milone M. Robotic Surgery and Functional Esophageal Disorders: A Systematic Review and Meta-Analysis. Journal of Personalized Medicine. 2023; 13(2):231. https://doi.org/10.3390/jpm13020231

Chicago/Turabian Style

Vertaldi, Sara, Anna D’Amore, Michele Manigrasso, Pietro Anoldo, Alessia Chini, Francesco Maione, Marcella Pesce, Giovanni Sarnelli, Giovanni Domenico De Palma, and Marco Milone. 2023. "Robotic Surgery and Functional Esophageal Disorders: A Systematic Review and Meta-Analysis" Journal of Personalized Medicine 13, no. 2: 231. https://doi.org/10.3390/jpm13020231

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop